Teeple, A. and Muser, E. 2017. Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s6. DOI:https://doi.org/10.25251/skin.1.supp.5.